Navigation Links
BioElectronics Launches '1 Day Breast Augmentation Recovery Kit'
Date:3/13/2008

Meets the Growing Demand for Quicker Surgical Recoveries

FREDERICK, Md., March 13 /PRNewswire-FirstCall/ -- BioElectronics Corporation (BIEL) announces the product launch of its Breast Recovery Kit, for the relief of edema and post operative discomfort.

Developed by Dr. Barry Eppley, MD, DMD, the 1 Day Breast Recovery Kit allows breast surgery patients to return to their active lives the day after surgery. Using the patented technology, ActiPatch relieves edema and discomfort without drugs, ice, or topical ointments. Priced below $50.00 it is an excellent alternative to pain pumps, which pose a risk of infection, or oral analgesics and anti-inflammatory medications -- which many patients prefer not to take or cannot tolerate.

Dr. Barry L. Eppley is an extensively trained and unique plastic surgeon. Dr. Eppley received a Doctor of Medicine degree from Washington University in St. Louis as well as a Doctor of Dental Medicine degree from the University of Pennsylvania in Philadelphia. Dr. Eppley completed training in Oral and Maxillofacial Surgery at Barnes Hospital and St. John's Mercy Medical Center Hospital while in St. Louis. He furthered his training in General Surgery, Craniofacial and Cleft Surgery as well as full training in Plastic and Reconstructive Surgery at Indiana University. As a result of this education, Dr. Eppley is both a licensed physician and dentist and board certified in the specialties of Plastic and Reconstructive Surgery as well as Oral and Maxillofacial Surgery. This background brings a diverse experience and perspective to the requirements needed for facial plastic, craniofacial and maxillofacial, and cosmetic body contouring surgeries. For more visit: http://www.dreppley.com.

"We are thrilled and quite fortunate to have such a talented surgeon and educator as Dr. Eppley assisting in our product development. We look forward to his insight and help in our mission to change the way people heal," said BioElectronics' President Andrew Whelan.

ActiPatch(TM) is a drug-free, anti-inflammatory patch with an embedded battery operated microchip that delivers weeks of continuous pulsed therapy for less than a dollar a day. The unique ActiPatch(TM) delivery system, using patented technology, provides a cost-effective, patient friendly method to reduce soft tissue pain and swelling.

ActiPatch has regulatory clearance by the FDA for the treatment of edema following blepharoplasty.

For more information visit http://www.bioelectronicscorp.com or call 866-757-2284.


'/>"/>
SOURCE BioElectronics Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. BioElectronics Corporation Announces Singapore and Malaysia Sales
2. BioElectronics Corporation Announces Distribution Agreement With TSS Medical of Italy
3. BioElectronics Announces Canadian Retail Product Launch
4. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
5. Novozymes Launches Enzyme to Reduce Acrylamide in Food
6. Enova Medical Launches Exos Corporation
7. Elekta Launches New Linear Accelerator at 2007 ESTRO to Expand Cancer Treatment Availability
8. Signalifes Dr. Harmison Launches Award-Winning Ambulatory Heart Monitor
9. ThirdBiotech Networking Group Launches
10. BioReliance Launches Next-Generation Genotoxicity Screening Service
11. Midwest Research Institute Launches Center for Biological Safety and Security (CBS2)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... , ... May 26, 2016 , ... ... company, today announced several positive developments that position the Company for the future. ... of the transaction, Craig F. Kinghorn has been appointed Chairman of the Board, ...
(Date:5/25/2016)... ... May 25, 2016 , ... Founder of the Fitzmaurice ... surgery and surgery of the hand by the National Board of Physicians and ... above and beyond in his pursuit of providing the most comprehensive, effective treatment ...
(Date:5/25/2016)... (PRWEB) , ... May 25, 2016 , ... ... U.S. Food and Drug Administration (FDA) has granted the company’s orphan drug designation ... company’s second orphan drug designation granted by the FDA. , Spinocerebellar ataxia ...
(Date:5/23/2016)... , ... May 23, 2016 , ... The need for blood donations in South Texas ... by the South Texas Blood & Tissue Center, blood donations are on the decline. In ... and they are down 21 percent in South Texas in the last four years alone. ...
Breaking Biology Technology:
(Date:3/15/2016)... New York , March 15, 2016 ... new market report published by Transparency Market Research "Digital Door ... Trends and Forecast 2015 - 2023," the global digital door ... US$ 731.9 Mn in 2014 and is forecast to grow ... 2023. Growth of micro, small and medium enterprises (MSMEs) across ...
(Date:3/14/2016)... -- NXTD ) ("NXT-ID" or the "Company"), a ... airing of a new series of commercials on Time Warner ... st .  The commercials will air on Bloomberg TV, Fox ... Street show. --> NXTD ) ("NXT-ID" or the ... announces the airing of a new series of commercials on ...
(Date:3/11/2016)... HANOVER, Germany , March 11, 2016 ... - Cross reference: Picture is available at AP Images ( ... scanner from DERMALOG will be used to produce the new refugee ... of other biometric innovations, at CeBIT in Hanover ... LF10 scanner from DERMALOG will be used to produce the new ...
Breaking Biology News(10 mins):